Showing results (21-30 of 2,411) with videos related to
Sort By:
Pageof 242
Pharmacoeconomics|February 3, 2007
The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: state-level evidence from 1997 to 2003Frank R LichtenbergAdvances in Health Economics and Health Services Research|June 26, 2010
The effect of drug vintage on survival: micro evidence from Puerto Rico's Medicaid programFrank R LichtenbergHealth Affairs (Project Hope)|September 18, 2001
Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPSF R LichtenbergForum for Health Economics & Policy|August 18, 2019
The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-use FilesFrank R LichtenbergHealth Affairs (Project Hope)|August 9, 2011
Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-beingFrank R LichtenbergHealth Economics|July 18, 2008
Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003Frank R LichtenbergExpert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series dataFrank R LichtenbergInternational Journal of Health Economics and Management|November 24, 2016
The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000-2011Frank R LichtenbergJournal of Pharmaceutical Policy and Practice|June 21, 2024
Do newer drugs treat fewer diseases, controlling for time since launch? Evidence from France and the U.SFrank R LichtenbergDisability and Health Journal|February 3, 2019
The impact of access to prescription drugs on disability in eleven European countriesFrank R LichtenbergPageof 242